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Abstract 
Choline acetyltransferase and vesicular acetylcholine-transporter genes are adjacent and coreg- 
ulated. They define a cholinergic locus that can be turned on under the control of several factors, 
including the neurotrophins and the cytokines. Hirschprung's disease, or congenital megacolon, is
characterized by agenesis of intramural cholinergic ganglia in the colorectal region. It results from 
mutations of the RET (GDNF-activated) and the endothelin-receptor genes, causing a disregula- 
tion in the cholinergic locus. 
Using cultured cells, it was shown that the cholinergic locus and the proteins involved in 
acetylcholine (ACh) release can be expressed separately ACh release could be demonstrated by 
means of biochemical and electrophysiological assays even in noncholinergic ells following 
preloading with the transmitter. Some noncholinergic or even nonneuronal cell types were found 
to be capable of releasing ACh quanta. In contrast, other cells were incompetent for ACh release. 
Among them, neuroblastoma N18TG-2 cells were rendered release-competent by transfection 
with the mediatophore gene. Mediatophore is an ACh-translocating protein that has been puri- 
fied from plasma membranes of Torpedo nerve terminal; it confers a specificity for ACh to the 
release process. 
The mediatophores are activated by Ca2+; but with a slower time course, they can be desensi- 
tized by Ca -"+. A strictly regulated calcium microdomain controls the synchronized release of ACh 
quanta at the active zone. In addition to ACh and ATP, synaptic vesicles have an ATP-dependent 
Ca 2+ uptake system; they transiently accumulate Ca R+ after a brief period of stimulation. Those 
vesicles that are docked close to Ca 2+ channels are therefore in the best position to control the 
profile and dynamics of the Ca R+ microdomains. Thus, vesicles and their whole set of associated 
proteins (SNAREs and others) are essential for the regulation of the release mechanism in which 
the mediatophore s ems to play a key role. 
Index Entries: Cholinergic neurons; gene regulation; choline acetyltransferase; v sicular acetyl- 
choline transporter; acetylcholine r lease, mediatophore; presynaptic proteins. 
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The Vesicular Acetylcholine 
Transporter (VAChT) 
VAChT was first identified at the genomic 
level by Alfonso et al. (1993) who showed that 
impaired cholinergic function in Coenorhabditis 
elegans mutants was linked to the UNC17 gene. 
The protein encoded showed good homology 
with the monoamine vesicular transporters 
VMAT1 and VMAT2 characterized earlier 
(Erikson et al., 1992; Liu et al., 1992; Schuldiner, 
1992). Taking advantage of the homogenous 
population of cholinergic motoneurons of the 
Torpedo electric lobe, Varoqui et al. (1994) 
screened the corresponding cDNA library 
using a UNC17-radiolabeled probe and iso- 
lated a full-length clone. Demonstrating that 
the encoded putative cholinergic transporter 
was indeed the real acetylcholine transporter 
(VAChT) came from transfection experiments. 
Cells transfected with a plasmid encoding this 
transporter bound the specific blocker vesami- 
col with an affinity similar to that of synaptic 
vesicles (Varoqui et al., 1994); after loading 
with ACh as described by Isra61 et al. (1994), 
the transfected cells accumulated the neuro- 
transmitter in a bound pool and this was in- 
hibited by vesamicol (Erickson et al., 1994). The 
range of vesamicol concentration that inhibited 
transport was in agreement with previous 
work on isolated synaptic vesicles (Bahr and 
Persons, 1986a,b; Diebler and Talarmain, 1989). 
The kinetic parameters of ACh transport mea- 
sured in PC12 cells transfected with human 
VAChT corresponded to those of synaptic 
vesicles (Varoqui and Erickson, 1996) that were 
purified from Torpedo electric organ by classical 
techniques (Isra61 et al., 1968, 1970, 1980; 
Whitlaker et al., 1972). 
A Cholinergic Genomic Locus 
It was interesting that the VAChT gene was 
located at the 5' end of the noncoding region of 
the choline acetyltransferase (CHAT) gene 
(Erickson et al., 1994; B6janin et al., 1994) at a 
site that was initially thought o be an intron. In 
neurotransmitter systems, this colocalization of
two genes involved in complementary func- 
tions seems to be unique; it suggests that syn- 
thesis and storage of ACh are tightly controlled 
and coregulated (Berrard et al., 1995; Berse and 
Blusztajn, 1995). In humans the two genes are 
located on chromosomes 10 at 10qll 2 (Fig. 1). 
Five possible promoters for ChAT were identi- 
fied in rat and a diversity of mRNA species 
have been characterized (B6janin et al., 1992; 
Misawa et al., 1992; Wu and Hersh, 1994; 
Cervini et al., 1995). Such a diversity might be 
important for the coexpression of different 
phenotypes controlled by complex splicing 
patterns for ChAT at the level of three exons, R, 
N, and M, in the noncoding sequence. The 
VAChT gene is located between R and N, and 
shares at least two R promoters with CHAT. In 
addition, VAChT has two specific promoters, 
V1 and V2 (Cervini et al., 1995). 
The adjacent localization of these two genes 
seems typical for the cholinergic system. The 
VMATs genes and the genes encoding cate- 
cholamine synthesizing enzymes are not linked 
in a comparable way. From a general point of 
view, VAChT and VMATs accomplish a homol- 
ogous function: They concentrate the respec- 
tive transmitters in vesicles or granules by 
exchange for protons that were accumulated 
by V-ATPase. However, it should be empha- 
sized that they operate at very different cyto- 
plasmic concentrations. The K~ of VMATs for 
monoamines i in the ~M range, whereas that 
of VAChT for is quite high, in the mM range, 
which corresponds to the elevated ACh con- 
centration (20-30 mM) in the cytoplasm 
(Dunant et al., 1974; Katz and Miledi, 1977; 
Morel et al., 1978). In addition, the dynamics of 
dopamine and noradrenaline are different 
since dopa-decarboxylase is in the cytoplasmic 
compartment whereas dopamine-~-hydroxy- 
lase in intragranular. The significance of the 
elevated cytosolic ACh level is certainly related 
to its mode of release, which might differ con- 
siderably from that of monoamines ( ee below). 
In summary, the adjacent localization of 
VAChT and ChAT genes defines a cholinergic 
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Fig. 1. Regulation of tile cholinergic locus. The 
cholinergic locus is depicted as two adjacent genes of 
the human chromosome 10 (10ql 1.2) that also carries 
the RET gene At the cell membrane, endothelin, NGF, 
GDNF, and LIF interact with their respective receptors, 
activating either cAMP-dependent phosphorylation, or 
tyrosine kinase phosphorylation followed by a cascade 
of kinases (STATS) As a result, the cholinergic locus, 
the genes involved in transmitter elease, and those of 
Ca2+-channel expression are turned on. In parallel, 
retinoic acid, after binding to its receptor, turns on the 
cholinergic locus. CRE and RARE sequences are seen 
at the genomic level. Mutations at the level of the 
GDNF/RET and of the endothelin system were found 
in Hirschprung's disease. 
operon that is expected to be switched on in a 
coordinated manner in order to regulate the 
compartmentation of ACh within the neuron 
and adapt ACh metabolism to environmental 
changes. 
The physiological role of VACht would be to 
increase the concentration of the transmitter 
and build up a store that can be mobilized in 
two ways. 
First, if the cytoplasm becomes acidic, an 
immediate l akage of vesicular ACh and ATP 
takes place supporting ACh release from the 
cytoplasm but also the synthesis of ACh that 
depends of ATP. Several metabolic onditions 
(glycolysis for example) may acidify the cyto- 
plasm, and signal the mobilization of vesicular 
ATP and ACh stores. 
Second, a docked vesicle on the site of 
release would feed the "releasing ate" with a 
much higher transmitter concentration than in 
the cytoplasm leading to larger mepps. The 
essential role of VACht may be observed after 
vesamicol action, when the ACh stores are 
exhausted, the mechanism looses its efficacy 
but is still at work. Similar observations come 
from studies on C. elegans mutants for VACht, 
the ACh storage in vesicles eems essential to 
maintain release, but VACht itself is not nec- 
essary for the translocation step, that depends 
of a membrane gate that we discuss in a later 
section. 
Regulation 
of the Cholinergic Operon 
A turning point in the research of the cholin- 
ergic phenotype was made possible by the use 
of sympathetic neurons in culture. The factor 
CDF-LIF (cholinergic differentiation factor/ 
leukemia inhibitory factor), present in muscle 
conditioned-culture medium, was seen to 
switch off the adrenergic phenotype (i.e., a 
decrease in tyrosine hydroxylase) and to turn 
on the ChAT gene (Yamamori et al., 1989). The 
role of CDF-LIF was recently confirmed with 
the additional demonstration that VAChT was 
coexpressed with ChAT (Berrard et al., 1995; 
Berse and Blusztajn, 1995; Misawa et al., 1995; 
Varoqui et al., 1996). Other neuropoietic factors 
such as CNTF (ciliary neurotrophic factor) are 
also able to reroute the developmental f te of 
adrenergic neurons towards the cholinergic 
phenotype. Apparently, CDF-LIF and CNTF 
may seem to be unrelated cholinergic differen- 
tiation factors. However, they were shown to 
share a common -helical framework that is 
also present in other compounds, such as 
hematopoietic cytokines (interleukins 6 and 3, 
interferons ctand ~); this structural homology 
has been recently documented byBazan (1991). 
An example in which a perturbation of the 
cholinergic locus leads to a severe disease is 
Hirschprung's congenital megacolon. Normally, 
cells of the neural crest migrate towards the 
terminal intestine forming cholinergic ganglia 
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that innervate smooth muscle cells, these gan- 
glia are absent in Hirschprung's disease. It was 
recently demonstrated that familial forms of 
Hirschprung's disease result from a mutation of 
the oncogene RET (Angrist et al., 1993; Lyonnet 
et al., 1993; Mulligan et al., 1993; Edery et al., 
1996, 1994; Scuchardt et al., 1994; Pasini et al., 
1995). RET is localized on human chromosome 
tO (10qll 2) like VAChT and CHAT. It would 
therefore be interesting to know the distance 
separating RET from the cholinergic locus. 
Whatever the distance, a crucial question is why 
RET deletion leads to degeneration f the cholin- 
ergic ganglia of the colon. The ligand that acti- 
vates RET is a factor called GDNF (glial cell 
line-derived neurotrophic factor) (Ibanez and 
Persson, 1991; Lin et al., 1993; Trupp et al., 1996). 
GDNF exerts atrophic influence on different 
classes of peripheral and central neurons, in- 
cluding motoneurons (Henderson et al., 1994; 
Oppenheim et al., 1995; Sargot et al., 1996). Mice 
lacking GDNF or RET do not survive since they 
have renal agenesis, a decreased number of neu- 
rons in several peripheral ganglia nd absence of 
enteric neurons like in Hirschprung's disease 
(Moore et al., 1996; Pichel et al., 1996; Sanchez 
et al., 1996). The activation of RET by GDNF 
involves a complex multicomponent receptor 
(Treanor et al., 1996); it triggers tyrosine-kinase 
activity, leading to a cascade of phosphorylation 
events that results in neuron survival. This 
effect has been demonstrated for dopaminergic 
neurons and also for cholinergic motoneurons a
measured by an increase in ChAT activity 
(Oppenheim et al., 1995; Zurn et al., 1994). 
Factors Controlling Presynaptic 
Expression of Cholinergic Genes 
Figure 1 shows that the cholinergic locus can 
be activated by signals coming from several 
different signaling pathways. As mentioned 
above, cytokines (CDF-LIF, CNTF) and GDNF 
exert their action initially through a receptor 
dimerization followed by the activation of a 
tyrosine kinase. The following cascade of bio- 
chemical reaction results in activation of tran- 
scription factors such as STATS (signal trans- 
ducers and activators of transcription) (Curtis 
et al., 1994). In Hirschprung's disease, the RET 
tyrosine kinase link has already been men- 
tioned, but the disease is also associated with 
gene defects in a different pathway, involving 
the endothelin-endothelin receptor system, 
here, the regulation occurs through aG protein- 
coupled phosphorylation involving cAMP and 
protein kinase C. The expression of cholinergic 
genes might also respond to this signaling sys- 
tem (Salomon et al., 1996). Such a response is of 
particular interest since it is known that protein 
kinase C and cAMP regulate the expression of 
proteins implicated in ACh release (see below). 
Neurotrophins like NGF and BDNF are 
believed to act through other phosphorylation 
pathways, one of which involves the cAMP- 
responding system CREB-CRE (cAMP respon- 
sive element [protein]). It has been shown that 
cAMP up regulates both ACh synthesis and 
release in some cell lines (Blusztajn et al., 1992) 
and the release process in other lines (Falk- 
Vairant et al., 1996). 
Still another pathway capable of switching 
on the cholinergic locus involves retinoic acid 
that binds to intracellular receptors imilar to 
steroid or thyroxin receptors. The complex acti- 
vates the expression of ChAT and VAChT at the 
genomic level by reacting with RARE (retinoic 
acid responsive lements) (Berrard et al., 1995; 
Berse and Blusztajn, 1995). 
Is Expression of the Cholinergic 
Locus Coordinated 
with That of the Release Process? 
It may be expected that the expression of 
ChAT and VAChT is coordinated with the 
expression of proteins supporting release. To 
test this, ACh synthesis and storage, on one 
side, and ACh release, on the other, must be 
measured separately. This experiment was re- 
cently performed by artificially filling with 
ACh cells that normally do not contain the neu- 
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rotransmitter (Isra61 et al., 1994). ACh release 
from these cells was tested either biochemically 
(Isra61 and Lesbats, 1981) or in real-time by an 
electrophysiological assay. It was found in this 
way that many cell types that do not express 
ChAT and VAChT are indeed able to produce 
Ca2§ quantal ACh release (Isra61 
et al., 1994; Falk-Vairant et al., 1996a,b,c,d, 
1994; Morimoto et al., 1995). This implies that 
the release machinery can be expressed inde- 
pendently of ChAT and VAChT. However, 
cholinergic neurons can both synthesize and 
release ACh; there the two systems have to be 
turned on by some coordinated regulation. 
For the release and its regulation, the prob- 
lem is complex since many proteins are in- 
volved. The approach can be simplified by 
separately considering the proteins that are 
more specifically related to the release of ACh 
and those that are common to all releasing cells. 
The latter include voltage-gated Ca2+ channels 
and the components of the T- and V-SNAREs 
(Rothman, 1994) that govern the traffic of intra- 
cellular membranes at the active zone as they 
do in the Golgi apparatus. Obviously, these 
proteins (the T-SNAREs syntaxin and SNAP-25 
at the plasma membrane, and the V-SNARE 
VAMP/synaptobrevin on synaptic vesicles) 
must be expressed in every type of cell. The 
same is true for V-ATPase, which functions to 
accumulate protons in intracellular organelles; 
in neurons this process is responsible for the 
driving force for concentrating transmitters 
into granules or vesicles. 
In cholinergic neurons, one would expect 
that the expression of ChAT and VAChT is 
coordinated in some way to a component of 
the release machinery that would confer a 
certain specificity for ACh. A protein support- 
ing such ACh specificity has been identified 
and named mediatophore (see description 
below). However, the mediatophore was found 
to be a homo-oligomer of a 15-kDa proteolipid 
that is also a component of the membrane 
sector of the V-ATPase. This 15-kDa element in 
itself cannot therefore be considered as a 
cholinergic-specific protein. However, what 
may be more characteristic for cholinergic 
neurons is the mechanism that directs the 
15 kDa into the plasma membrane. This ques- 
tion was recently addressed by Leroy and 
Meunier (1995) who expressed the 15 kDa in the 
Xenopus oocyte. They showed that injecting the 
mRNA of the 15 kDa alone was less efficient in 
inducing ACh release than injecting the whole 
set of poly(A*) mRNAs extracted from choliner- 
gic neurons. In the former, the 15-kDa protein 
accumulated chiefly in intracellular mem- 
branes. Therefore, another protein is probably 
required for directing the 15 kDa subunit at the 
plasma membrane where it is assembled to 
form the mediatophore homo-oligomer. This 
process may coordinate the events associated 
with expression ofthe cholinergic locus and ex- 
pression of the specific step of ACh release. In 
this respect, cAMP-dependent systems may be 
an important regulation pathway since they can 
upregulate both ACh synthesis and ACh re- 
lease, as well as CaR+-channels in some cells 
(Isra6l et al., 1994; Berse and Blusztajn, 1995; 
Falk-Vairant et al., 1996a). 
Calcium Microdomains 
and Transmitter Release 
Calcium has long been known to be the 
trigger for ACh release. By opening voltage- 
dependent Ca 2+ channels, the action potential 
leads to an abrupt increase of free Ca 2+ at the 
cytoplasmic orifice of the channels. For a brief 
instant and in restricted areas (microdomains), 
Ca 2+ reaches a submillimolar concentration. 
These Ca ~+ microdomains were visualized by 
Llinas et al. (1992) in the squid giant synapse 
by using a modified, low affinity, aequorin 
dye. It is expected that the mechanism of 
neurotransmitter r lease that would be close to 
Ca 2+ channels, would thus operate within 
microseconds in response to a relatively high 
Ca 2+ concentration. 
A second action of Ca 2+ is the desensitiza- 
t ion -or  fatigue--of release Desensitization 
takes place at a slow rate but it requires micro- 
molar Ca 2§ concentrations. Both the Ca 2+ acti- 
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vation (low affinity, high speed) and the Ca 2+ 
desensitization (high affinity, low speed) of 
ACh release have been demonstrated by using 
either intact nerve terminals, or synaptosomes, 
or reconstituted presynaptic membranes, or 
purified mediatophore incorporated in ACh- 
filled proteoliposomes (I ra61 et al., 1987; Isra61 
and Dunant, 1993; Dunant and Isra61, 1995). 
The kinetics and the diffusion volume of 
Ca -"+ microdomains must be strictly controlled 
at the active zone. In fact, the synaptic vesicles 
that are docked at the membrane are in the best 
position to buffer local calcium. Synaptic vesi- 
cles are indeed able to actively take up Ca 2§ in 
the presence of ATP, they can accumulate large 
amounts of Ca 2+, to an average concentration f 
20 mM (isra61 et al., 1980; Michaelson et al., 
1980; Dunant et al., 1980). After a brief nerve 
stimulation, calcium transiently accumulates in
vesicles (Fig. 2) (Parducz et al., 1987, 1994; 
Parducz and Dunant, 1993; Buchs and Muller, 
1996; Blaustein et al., 1996). The number of exo- 
cytotic events increases significantly during the 
first few minutes following a period of synaptic 
activity (Parducz et al., 1994). This postactivity 
exocytosis may efficiently contribute to the 
process of Ca 2+ extrusion. By finely tuning the 
local Ca 2+ kinetics at the active zone, the vesi- 
cles may modulate the proportion of release 
sites that are open, closed, or desensitized. 
Conditions that impair Ca R+ sequestration are 
therefore xpected to cause desensitization a d 
desynchronization f release. 
The perturbation of Ca 2+ microdomains can 
have other consequences on quantal ACh 
release. Careful electrophysiological investiga- 
tion using neuromuscular nd nerve-electro- 
plaque junctions revealed that the classical 
quantum of transmitter (approx 10,000 ACh 
molecules) is composed of a mean of 10 sub- 
units (Kriebel and Gross, 1974; Kriebel, et al., 
1976; Muller and Dunant, 1987; Girod et al., 
1995). Individual asynchronous release of 
subunits (subminiature potentials) becomes 
prominent under conditions that alter the Ca 2+ 
microdomain (energy shortage, exhausting 
stimulation, clostridial neurotoxins, and so on; 
(Dunant et al., 1988). 
Under physiological conditions, one can 
hypothesize that one microdomain synchro- 
nizes the release of a mean of 10 subunits at 
each site. At the arrival of a nerve impulse, the 
simultaneous opening of all the calcium chan- 
nels causes imultaneous release at the different 
sites. This interpretation implies that the quanta 
are produced instantly at the membrane by 
channel-like proteins ynchronized by the Ca 2+ 
microdomains. This is fundamentally different 
from the current heories whereby the quanta 
arise from the stochastic evacuation of pre- 
formed packets and the role of Ca 2+ is only to 
increase the probability of release. One question 
remained: Is there in the presynaptic membrane 
a channel protein that would be activated at 
high Ca 2§ slowly desensitized atlow Ca 2+, and 
would release ACh in a quantal manner? 
Mediatophore, the Acetylcholine 
Releasing Unit 
The starting materials for this approach were 
synaptosomes from the Torpedo electric organ. 
This population of purely cholinergic nerve 
terminals have been particularly useful for 
investigating Ca2+-dependent ACh release 
(Morel et al., 1977). In usual experiments, ACh 
release by synaptosomes is measured by bio- 
chemical techniques (Isra61 and Lesbats, 1981, 
1982). It was suspected, but not established, 
that synaptosomes isolated from their natural 
environment retain the essential property of 
physiological release, which is to emit quanta 
of neurotransmitter. We addressed this ques- 
tion by using embryonic Xenopus myocytes as 
ACh detectors for real-time recording of quan- 
tal ACh release. A suspension of Torpedo elec- 
tric organ synaptosomes was applied to the 
myocyte culture. Soon after application, we 
were lucky enough to record bursts of minia- 
ture potentials. These arose from pulses of ACh 
since they were sensitive to curare. Miniatures 
generated by Torpedo synaptosomes closely 
resembled those occurring normally during 
the early phase of synaptogenesis in Xenopus 
nerve-muscle cultures (Girod et al., 1992). 
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On this basis, a long series of reconstitution 
experiments was undertaken with the aim to 
isolate the putative ACh-releasing protein. A 
first approach was to examine whether or not 
synaptosomal ghosts depleted from their vesicle 
and cytosolic ontent were still able to release 
the transmitter. Such ghosts were prepared from 
Torpedo nerve terminals and refilled with ACh. 
Indeed, they were found to release the transmit- 
ter upon Ca R+ entry. The amounts released were 
in proportion to the ACh content of the ghosts 
(Isra61 et al., 1981). Reconstitution experiments 
of this kind were also successfully performed by 
using mammalian brain synaptosomes (Meyer 
and Cooper, 1983; Isra61 et al., 1988) and rat 
neuromuscular junction (Isra61 et al., 1990). 
Then, the proteoliposome approach was 
used as a functional assay to purify the very 
component of the presynaptic membrane that 
would support Ca2§ transmitter 
release. Fractions were prepared from the 
plasma membrane of Torpedo nerve terminals, 
reincorporated into proteoliposome mem- 
brane, and tested for release. This resulted in 
the identification and characterization f a 
lipoprotein that carried the expected ACh- 
translocating properties. This protein was 
named mediatophore (Isra61 et al., 1984, 1986). 
Electron microscopic observation using neg- 
ative staining revealed that the native medi- 
atophore is a pentameric structure of 8-nm 
diameter with a central hole. Its molecular 
weight is approx 220 kDa. Since it presents itself 
as a homo-oligomer of single 15-kDa subunit 
(Isra61 et al., 1984; Birman et al., 1986), one can 
expect that the native protein associates 15 sub- 
units. Each branch of the pentamer would 
therefore be composed of three subunits. 
From a partial sequence of the 15-kDa sub- 
unit, a nucleotide probe was synthesized. By 
screening a cDNA library derived from Torpedo 
electric lobe, a clone corresponding to the full- 
length insert of the 15-kDa protein was selected 
and sequenced (Birman et al., 1990). It turned 
out that the 15-kDa subunit of the Torpedo me- 
diatophore showed ahigh degree of homology 
with a subunit found in other transmembrane 
systems, uch as the protonophore (c-subunit) of 
the bovine V-ATPase (Nelson, 1992), and a pro- 
tein found in invertebrate gap junctions (Finbow 
et al., 1991). This 15-kDa protein appears there- 
fore as a highly conserved element included in 
several different protein complexes, all involved 
in membrane translocation processes (Finbow 
et al., 1995). By using immunochemical tech- 
niques, it was seen that the oligomeric form of 
the Torpedo mediatophore is localized at the 
"active zones" of the presynaptic membrane 
(Fig. 3) (Brochier et al., 1993). 
As mentioned above, the proteoliposomes 
containing the mediatophore r leased ACh 
with several typical features of the natural nerve 
terminals. Like natural synaptosomes, proteo- 
liposomes containing mediato, phore as unique 
protein released ACh on a Ca ~+ challenge (low 
affinity), but release was desensitized when 
the proteoliposome interior was exposed to 
Ca 2+ (high affinity) for several seconds or min- 
utes (Isra01 et al., 1987). In addition, release was 
accompanied by the transient occurrence of 
large intramembrane particles in the proteolipo- 
somes (Brochier et al., 1992), as was also ob- 
served in native synaptosomes (I ra61 et al., 
1981) and in the natural synapses (Garcia- 
Segura et al., 1986; Muller et al., 1987). 
When the whole set of mRNAs extracted 
from nerve cells is injected into a Xenopus 
oocytes, the latter should inherit typical neu- 
ronal components such as membrane r ceptors 
and channels (Barnard and Bilbe, 1986), as well 
as the equipment for neurotransmitter synthe- 
sis and release. Successful expression of ACh 
synthesis and of neuronal ionic conductances 
were obtained by Gundersen et al. (1984, 1985) 
by injecting oocytes with mRNAs from electric 
lobes. The electric lobes are paired nuclei of the 
Torpedo CNS containing more than 100,000 
electromotoneurons, thatis, cells that are homol- 
ogous to the well-known motoneurons. 
We injected electric-lobe mRNAs into oocytes 
and demonstrated that Ca2§ ACh 
release was also expressed in the primed 
oocytes (Cavalli et al., 1991). Like in proteolipo- 
somes, the precise dependency of ACh release 
upon Ca  2+ concentration a d the pharmacology 
of release closely matched the characteristics 
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When ACh-loaded ceils were transfected 
with antisense oligonucleotides against he 
rat 15-kDa mRNA proteolipid, ACh release 
was inhibited (Isra61 et al., 1994). Antisense 
experiments indeed suggested that the 15 kDa 
is necessary for release, but many other pro- 
teins are also necessary. We were aware that 
the function of V-ATPase might also have been 
impaired, resulting in a depression of release 
through avesicular mechanism. The key ques- 
tion was whether the mediatophore by itself 
would support release in a living cell, as sug- 
gested by proteoliposome experiments. To this 
end, we decided to transfect cells with medi- 
atophore cDNA in order to render them able to 
release ACh. 
In preliminary experiments, we found that 
most cells can be filled by ACh from the ex- 
ternal medium under appropriate conditions 
(Isra61 et al., 1994). ACh-filled cells were tested 
for Ca2+-dependent ACh release by using the 
luminescence method (Isra61 and Lesbats, 1981, 
1982). In parallel experiments, some cells from 
the same culture were transferred into a culture 
of Xenopus embryonic myocytes (myoballs) that 
were used as sensitive and rapid detectors for 
the released ACh (Evers et al., 1989). Individual 
ACh-filled cells were moved into contact with 
the patched myoball and held by a fine-tipped 
glass pipet through which they could be elec- 
trically stimulated. Evoked ACh release was 
detected as nicotinic inward currents recorded 
from the voltage-clamped myoball. Under 
these conditions, certain cell lines (NG108-15; 
C6BU-1; L-M(TK-) fibroblasts) released the 
neurotransmitter in a quantal and pulse-like 
manner (Fig. 4). As expected the responses 
were curare-sensitive and Ca2+-dependent 
(Falk-Vairant et al., 1996d). 
Other cell lines, however, such as the mouse 
N18TG-2 and NIE-115 neuroblastoma cells, 
were unable to release ACh (Isra61 et al., 1994; 
Zhong et al., 1995a,b). Actually, N18TG-2 cells 
were found to be deficient in both ChAT and 
VAChT, the proteins controlled by the cholin- 
ergic operon (Varoqui et al., 1996; Falk-Vairant 
et al., 1996d). Also they contained only low 
levels of mediatophore in their membranes 
(Isra61 et al., 1994). Were they release-deficient 
because they lacked the mediatophore? To test 
this, transfection of the N18TG-2 cells was per- 
formed by using a plasmid coding for the 
Torpedo mediatophore 15-kDa subunit. In the 
transfected cells the Torpedo protein was ex- 
pressed in the plasma membrane and ACh 
release was re-established, as assessed by both 
biochemical nd electrophysiological determi- 
nations. On electrical stimulation, the trans- 
fected cells generated in the adjacent myoball 
evoked currents that were curare-sensitive, 
Ca2+-dependent, and displayed iscrete am- 
plitude levels, like in naturally occurring 
synapses (Fig. 4) (Falk-Vairant et al., 1996b,c,d). 
Since N18TG-2 cells did not contain either 
ChAT and VAChT, it was clear that medi- 
atophore-induced quantal release could take 
place in the absence of the vesicular ACh trans- 
porter. Another cell line (Neuro2A) was investi- 
gated in coculture with myocytes, the release 
capability being tested by the frequency of 
miniature potentials. Native Neuro2A cells 
were inefficient for release, but they became 
efficient after transfection with CHAT. In this 
case, transmitter release was also probably 
operative in the absence of VAChT, since the 
two genes of the cholinergic locus are coregu- 
lated (Zhong et al., 1995a,b). 
It is concluded that provided that cells are 
filled with the transmitter, quantal ACh release 
can be demonstrated ven in the absence of 
ChAT and VAChT. When a cell is not competent 
for release, transfection ofm~diatophore cDNA 
is sufficient o restore the function, including 
the production of pulse-like quanta. 
Dissociation Between Transmitter 
Release and Vesicle Fusion 
A time coincidence between transmitter 
release and vesicle fusion was only observed in 
exceptional situations (Parducz and Dunant, 
1993; Heuser et al., 1979; Tarelli et al., 1992). 
In other experiments, the two processes were 
frankly dissociated intime (Garcia-Segura et al., 
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Fig. 3. Immunocytochemical localization of the vesicular acetylcholine transporter and of mediatophore in 
nerve terminals of the Torpedo electric organ. (A) A first anti-VAChT antibody was revealed by a gold-labeled 
second antibody VAChT is localized mainly in synaptic vesicles (Varoqui et al., 1995). (B) Immunocytochemical 
localization of mediatophore by an antibody directed against the homo-oligomer. The mediatophores form 
aggregates at the active zones of the plasma membrane (Brochier et al., 1993). 
seen in native synapses. Importantly, the 15-kDa 
subunit of the mediatophore was expressed in
the membranes of the mRNA-primed oocytes 
but not in controls. Thus, when the release 
process was expressed, the mediatophore was 
expressed as well (Cavalli et al., 1991). Antisense 
oligonucleotides directed against segments of 
the Torpedo 15-kDa mRNA were injected into 
oocytes together with the total poly(A § mRNAs 
of electric lobes. Strikingly, they abolished both 
ACh release and the expression f the 15-kDa 
mediatophore subunit. In contrast, a 15-kDa 
bovine-specific antisense probe did not affect 
either ACh release or the expression of the 
Torpedo 15-kDa subunit (Cavalli et al., 1993). 
It was also shown in these xperiments hat 
the primed oocytes utilized cytosolic ACh for 
release. Actually, as much as 99% of the ACh 
content was hydrolyzed when the oocytes were 
disrupted in the presence of cholinesterase, 
demonstrating that almost all their ACh was 
cytosolic. This confirmed previous observations 
with the Torpedo nerve terminals, that the 
cytosolic pool of ACh is used and renewed 
before the vesicular pool (Dunant et al., 1972; 
lsra61 et al., 1979). 
Reconstitution f ACh release in oocytes was 
confirmed by Alder et al. (1992) and extended to
glutamate r lease. As we have discussed above, 
Leroy and Meunier (1995) obtained evidence 
that another protein is probably required for di- 
recting the 15-kDa subunit at the plasma mem- 
brane where it can assemble and form the 
mediatophore homo-oligomer. 
Cell Lines Competent 
and Incompetent for Quantal ACh 
Release; Correction of a Release- 
Deficient Cell by Mediatophore 
Transfection 
The antisense xperiments have been re- 
peated using a cell line (NG108-15) known to 
express the cholinergic release mechanism. 
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Fig. 4. Restoration of quantal release in mediatophore-transfected cells. Cells were filled overnight with ACh, 
washed, and then harvested to be tested for transmitter elease. In the first test (upper traces), ACh release was 
elicited by application of the ionophore A23187 followed by calcium and.measured by a luminescence reaction 
(Isra61 and Lesbats, 1981). In parallel, cells were applied onto a culture of embryonic Xenopus myocytes. 
Individual cells were pushed with an electrode against a patch-clamped myocyte and stimulated electrically. 
Evoked transmitter release was recorded in real time from the myocyte. Neuroblastoma x glioma hybrid cells 
NG108 efficiently released the transmitter, but neuroblastoma N18TG-2 cells were incompetent for release. 
However, release could be re-established in N18TG-2 cells upon transfection with the mediatophore subunit 
cDNA. The electrophysiological tests showed that ACh release from transfected cells was quantal as in naturally 
occurring synapses (Falk-Vairant et al., 1996b,c,d). 
1986; Muller et al., 1987). An example of such a 
dissociation was demonstrated in the Torpedo 
electric organ submitted to a brief nerve stimu- 
lation (100 Hz during 12 s). Transmitter release 
took place during the first 10 s of the tetanus but 
images of vesicle fusion started to occur only 
after the end of activity, culminating at i min of 
the posttetanic recovery period (Parducz et al., 
1994). 
A still more dramatic dissociation between 
transmitter elease and vesicle fusion was 
recently reported at the frog neuromuscular 
junction. Synaptic vesicles were stained with 
the fluorescent marker FMI-43, then the rate of 
"destaining" (taken as a marker for exocytosis) 
was monitored together with the release of 
transmitter during the course of nerve stimula- 
tion. Under control conditions, the kinetics of 
destaining was roughly parallel to the rate of 
release for 1-2 min (Betz and Bewick, 1993). 
However, staurosporine, a protein kinase C 
inhibitor, fully abolished destaining but left 
synaptic transmission unaltered (Henkel and 
Betz, 1995). 
Another example of dissociation was found 
in Zn2+-treated synapses of Torpedo electric 
organ. Incubation of small pieces of tissue in 
250 ~tM ZnC12 irreversibly blocked the release 
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of ACh, but did not cause any significant alter- 
ation in the fine structure of resting nerve- 
electroplate junctions. Electrical stimulation at 
this stage resulted in Ca 2+ accumulation and 
massive vesicle fusion despite the fact that no 
transmitter was released. This experimental 
schedule created an unusual situation where 
the exo-endocytotic a tivity of synaptic vesicles 
could be activated independently from the 
release of transmitter (Parducz et al., 1997). 
The SNARE Proteins 
and Quantal Release 
As seen above, a host of proteins associated 
either with synaptic vesicles or with the plasma 
membrane are widely distributed among neural 
and nonneural cells. Synaptophysin is the most 
abundant protein associated with vesicle mem- 
branes, but surprisingly, suppression of synap- 
tophysin causes only a modest alteration, if any, 
of evoked and spontaneous quantal transmitter 
release (Alder et al.; 1992; Eshkind and Leube, 
1995; McMahon et al., 1996). When release is 
reconstituted in oocytes, however, antisynap- 
tophysin antisense oligonucleotides cause a 
reductiofl in release (Alder et al., 1992). On the 
other hand, alteration of proteins of the V- and 
T-SNARE family (Sollner and Rothman, 1994) 
affects transmission more seriously. Among 
these, VAMP/synaptobrevin, SNAP-25, and 
syntaxin are of special interest since they can be 
cleaved by clostridial toxins (Schiavo et al., 1992; 
Blasi et al., 1993), which results in interruption 
of the neurally evoked release of transmitter. 
However, some quantal transmitter release 
persists during the whole period of clostridial 
intoxication that can last for several weeks 
(Kriebel et al., 1976; Harris and Miledi, 1971; 
Thesleff et al., 1983). Moreover, evoked trans- 
mitter release can be partially restored by 
increasing Ca R+ entry or by using agents like 
latrotoxin (Molgo et al., 1990; Gansel et al., 
1987). Hence, by inactivating VAMP, SNAP-25, 
syntaxin, and possibly other proteins, clostridial 
toxins uncouple the release mechanism from its 
natural trigger, i.e., the abrupt elevation of 
calcium at the above-described microdomains. 
The very process involved in quantal release is 
still operational but its Ca "-+ trigger is perturbed. 
Expression of the SNARE proteins was also 
modified or suppressed in transgenic animals. 
In the absence of synaptotagmin, the sensitivity 
of neurally evoked release was strongly inhibi- 
ted, but spontaneous quantal release subsisted; 
it could still be greatly accelerated by hyper- 
tonicity or other techniques (Nonet et al., 1993; 
DiAntonio et al., 1993; Bommert et al., 1993; 
Broadie et al., 1995; Littleton and Bellen, 1995). 
A similar picture was obtained by suppressing 
VAMP/synaptobrevin or syntaxin (Broadie 
et al., 1995; Sweeney et al., 1995). The picture was 
therefore very similar to that of clostridial in- 
toxication. The mechanism supporting quantal 
release was still present, but its Caa+-dependent 
trigger was strongly perturbed. This family of 
proteins is therefore ssential for ensuring the 
physiological regulation and synchronization 
of quantal release, but not for supporting the 
most elementary step of release, i.e., the forma- 
tion of neurotransmitter quanta. 
Vesicular Docking Mechanisms 
The three proteins syntaxin, SNAP-25, and 
VAMP/synaptobrevin constitute a clostridial 
toxin-sensitive anchor. This complex has been 
purified by fractionation and immunoprecipi- 
tation experiments (Sollner et al., 1993; Shift 
et al., 1996). There are, in addition, two possible 
systems that may anchor the vesicles to the 
plasma membrane, the <, C2 ~ attachment and 
the synaptophysin-mediatophore link (Fig. 5). 
Several proteins hare a homologous stretch 
of sequence, which is the C2 domain. It is 
found in the vesicular protein synaptotagmin, 
in protein kinase C, and in the cytoplasmic 
protein, rabphilin. The latter can become asso- 
ciated to Rab3-GTP, and thereby to vesicle 
membranes. The C2 anchor binds directly or 
indirectly to the calcium channel as shown by 
immunoprecipitation experiments (Leveque 
et al., 1992; Horikawa et al., 1993). Decoy 
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C2 Docking Clostidrial docking Mediatophore docking 
VAMP 
Synaptotagmin Synaptobrevm Synaptophysin 
Ca ++Channel Ca ++Channel Ca ++Channel 
Fig. 5. Three docking links between synaptic vesicles and the plasma membrane. The "C2 docking" complex 
involves proteins with a C2 sequence (such as synaptotagmin, rabphilin, protein kinase C, and others) and a site 
at, or close to, the Ca ~+ channel. The "clostridial docking" complex refers to proteins that can be cleaved by 
botulism or tetanus toxins. They are Vamp/synaptobrevin, SNAP-25 and syntaxin. A third putative docking 
system involves synaptophysin, mediatophore, and physophilin. 
peptides homologous to the C2 domain or 
protein kinase C itself, perturb this C2 docking 
and alter transmission (Bommert et al., 1993). 
Similarly, interference with Rab-rabphilin 
attachment affects release in pituitary cells 
(Lledo et al., 1993). 
The third type of docking may involve two 
channel-forming proteins, synaptophysin and 
the mediatophore This possibility was sug- 
gested by the fact that synaptophysin (and also 
synaptobrevin) is immunoprecipitated with 
the 15-kDa protein (Galli et al., 1996), which is 
common to mediatophore and to the c-subunit 
of the V-ATPase membrane sector (Vo). In 
addition, another subunit of V-ATPase (39 kDa) 
was previously identified as physophilin, a
synaptophysin-binding protein (Thomas and 
Betz, 1990; Siebert et al., 1994). This docking 
system might link, in series through media- 
tophore and synaptophysin-Vo, the vesicle 
lumen to the extracellular space. This link is 
expected to be resistant o clostridial toxins. 
It may still function, like the C2 anchor, when 
the clostridial anchor (T- and V-SNAREs) is 
absent or cut. In fact, vesicles till dock to the 
membrane when the clostridial link is damaged 
(Broadie et al., 1995). However, a physiologi- 
cally intact clostridial l nk is likely to be essen- 
tial for controlling the shape and kinetics of 
the Ca 2+ microdomains, ensuring synchroniza- 
tion of release, and protecting mediatophore 
against desensitization. 
Conclusions 
In order to control a cholinergic phenotype, 
a neuron has to turn on the cholinergic locus 
but also must express the mediatophore at the 
plasma membrane in order to support quantal 
release of ACh. Synchronization of release 
with respect o the calcium trigger is regulated 
by a set of proteins that dock the vesicles at 
the active zones (Couteaux and P6cot- 
Dechavassine, 1970). The docked vesicles are 
expected to control the shape and the kinetics 
of Ca 2+ microdomains. The latter regulation is 
independent of the cholinergic phenotype 
since it is found in all synapses. 
From the work of Zimmermann and Denston 
(1977) we may consider that vesicle recycling 
is an essential feature of synaptic function 
since transmission would rapidly stop if 
recycling was blocked. Moreover knowledge of 
protein-protein teractions that support the 
dynamics of endo-exocytosis are now well 
documented by the work of Sudhof (1995). 
These essential contributions are compatible 
with our own views on the role of an inevitable 
gate, probably mediatophore, that supports 
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the final t rans locat ion steps of release: the 
del ivery of the smallest quantum of ACh. 
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